Combined cycloablation and gonioimplantation for treatment of glaucoma in dogs: 18 Cases (1992-1998)

Ellison Bentley, Paul E. Miller, Christopher J Murphy, James V. Schoster

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Objective - To evaluate a combined cycloablative and gonioimplantation technique for treatment of glaucoma in dogs. Design - Retrospective study. Animals - 18 adult dogs with glaucoma. Procedure - Medical records of dogs that received a valved gonioimplant and a cyclodestructive procedure (cyclocryoablation or diode laser cyclophotocoagulation) during a 6-year period were reviewed. Retention of vision and intraocular pressure control were assessed, as well as number and nature of complications. Results - 19 eyes of 18 dogs received a valved gonioimplant and either cyclocryoablation (n = 12) or diode laser cyclophotocoagulation (7). At ≥ 1 year after surgery, 11 of 19 eyes had vision and 14 of 19 eyes had intraocular pressure < 25 mm Hg. Two dogs (2 eyes) were lost to follow-up 3 and 6 months after surgery. Despite the alternative route for aqueous humor flow created by the gonioimplant, 7 eyes had increased intraocular pressure (27 to 61 mm Hg) < 24 hours after surgery. Other complications included excessive intraocular fibrin, focal retinal detachment, corneal ulcer, retinal hemorrhage, cataract, and implant migration. Conclusions and Clinical Relevance - Combined cycloablation and gonioimplantation appears to be a promising technique for retention of vision and control of intraocular pressure in dogs with glaucoma.

Original languageEnglish (US)
Pages (from-to)1469-1472
Number of pages4
JournalJournal of the American Veterinary Medical Association
Volume215
Issue number10
StatePublished - Nov 15 1999
Externally publishedYes

ASJC Scopus subject areas

  • veterinary(all)

Fingerprint Dive into the research topics of 'Combined cycloablation and gonioimplantation for treatment of glaucoma in dogs: 18 Cases (1992-1998)'. Together they form a unique fingerprint.

  • Cite this